Wednesday, 18 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

8:29 AM ET 8-K
Financial Results Ocugen, Inc. OCGN

Ocugen Financial Results

Ocugen reported Q3 2026 financial results, highlighting a cash position of $84.6 million with an expected runway into 2028. The company advanced its gene therapy pipeline, including the initiation of the Phase 3 ArMaDa3 trial for OCU410 and receiving provisional approval for OCU400 in The Bahamas.

Term
Q3 2026

“With three Phase 3 modifier gene therapy programs underway, Ocugen is executing against a clear strategy of advancing our pipeline and leveraging strategic partnerships to expand global reach and potentially bring our therapies to patients worldwide.”

Dr. Shankar Musunuri, Chairman, CEO and Co-Founder of Ocugen

“As we demonstrated in the third quarter, we remain focused on executing key clinical and regulatory milestones, expanding our commercial opportunities, and maintaining a disciplined approach as we advance toward the anticipated OCU400 Phase 3 topline data early next year.”

Dr. Shankar Musunuri, Chairman, CEO and Co-Founder of Ocugen
8:23 AM ET 8-K
Financial Results Global Indemnity Group, LLC GBLI

Global Indemnity Group Financial Results

Global Indemnity Group reported Q3 2026 net income of $8.9 million ($0.61 per share) and nine-month net income of $24.2 million ($1.65 per share). New CEO Jessica E. Buss highlighted that while the third quarter was softer due to maintaining underwriting standards in a softening property market, nine-month results ran well ahead of the prior year.

“I joined GBLI as CEO this week. I studied this company closely before accepting the role, and I came in knowing exactly where we stand and what we can become. Our results for the first nine months ran well ahead of last year. The third quarter came in softer, as we held to our underwriting standards while competitors cut property rates, and we owe our shareholders a plain account of that. We also owe them a plan.”

Jessica E. Buss, CEO of Global Indemnity

“Going forward, we will hold ourselves to one measure: sustained growth in premiums, earnings and book value per share at rates far beyond anything GBLI achieved since its founding.”

Jessica E. Buss, CEO of Global Indemnity
8:17 AM ET Form 4
Insider Selling Church & Dwight Co Inc CHD

Church & Dwight Co President and CEO Richard A. Dierker Sells $9.13M of Stock

Richard A. Dierker, President and CEO, sold 83,340 shares of Church & Dwight Co Inc at $109.59 a share, worth $9.13M in total on Nov 3, 2026. Shares held after the trade: 38,659 (-68.3%).

Value
$9.13M
Shares
83,340
Price
$109.59
Role
President and CEO
Holding change
-68.3%
Trade date
Nov 3, 2026
8:17 AM ET 8-K
Capacity Expansion Terawulf Inc. WULF

Terawulf Capacity Expansion: $19B Investment

TeraWulf executed a definitive EPC agreement with Fluor for the construction of three data center buildings at its Justified Data Campus in Kentucky, supporting a $19 billion lease with Anthropic. Additionally, Google LLC entered into credit support agreements to backstop Anthropic's lease obligations, significantly strengthening the project's financing profile.

Value
$19B
Counterparty
Anthropic, PBC
Term
20 years
8:16 AM ET 8-K
Investor Presentation Septerna, Inc. SEPN

Septerna Investor Presentation

Septerna announced the selection of SEP-204 as a development candidate for Graves’ disease and thyroid eye disease, supported by preclinical data presented at the 2026 American Thyroid Association Annual Meeting. The company also filed an updated corporate presentation for use in meetings with investors and analysts.

8:16 AM ET 10-Q
Financial Results Harmony Biosciences Holdings, Inc. HRMY

Harmony Biosciences Holdings Q3 2026 Results: Net Income $48.2M, Down 5.2% YoY

Harmony Biosciences reported net product revenue of $268.9 million for the third quarter of 2026, a 12.3% increase year-over-year. Net income for the nine months ended September 30, 2026, rose to $156.1 million compared to $136.2 million in the prior year, despite higher operating expenses driven by research and development.

Key figure
Net income $48.2M · -5.2% YoY
8:12 AM ET 8-K
Reverse Stock Split Jasper Therapeutics, Inc. JSPR

Jasper Therapeutics Reverse Stock Split

Jasper Therapeutics announced a 1-for-30 reverse stock split of its common stock, effective November 6, 2026. The split will reduce the number of outstanding shares from approximately 33.3 million to 1.1 million to increase the per-share trading price on the Nasdaq Capital Market. The authorized number of shares remains unchanged at 490 million, resulting in an increase in authorized but unissued shares available for future use.

8:11 AM ET 10-Q
Financial Results Safehold Inc. SAFE

Safehold Q3 2026 Results: Net Income $28.8M, Down 1.6% YoY

Safehold Inc. reported net income of $31.3 million for the quarter ended September 30, 2026, driven by $118.7 million in total revenues, including new hotel revenue streams. Total assets grew to $7.70 billion from $7.25 billion at year-end 2025, while the company maintained its quarterly dividend at $0.177 per share.

Key figure
Net income $28.8M · -1.6% YoY
8:11 AM ET 8-K
Executive Compensation Processa Pharmaceuticals, Inc. PCSA

Processa Pharmaceuticals Executive Compensation

Processa Pharmaceuticals appointed Gregory J. Flesher as Chief Operating Officer, effective November 4, 2026. Mr. Flesher will receive an annual base salary of $700,000, a target bonus of up to 60%, and an initial stock option grant representing 3.0% of the company's fully-diluted capital stock, contingent on shareholder approval of a new equity incentive plan.

8:11 AM ET 10-Q
Financial Results SmartRent, Inc. SMRT

SmartRent Q3 2026 Results: Net Loss of $3.91M, Loss Narrows

SmartRent, Inc. reported total assets of $289.1 million as of September 30, 2026, a decrease from $320.9 million at year-end 2025, primarily driven by lower cash and accounts receivable balances. Total liabilities also decreased from $88.8 million to $68.7 million during the same period. The company continues to focus on its 'Vision 2028' strategic plan while managing macroeconomic headwinds and leadership changes.

Key figure
Net loss $3.91M
8:10 AM ET 8-K
Leadership Change Electronic Servitor Publication Network, Inc. XESP

Electronic Servitor Publication Network Leadership Change

Thomas Spruce resigned from his roles as Director, COO, CFO, and Secretary effective October 29, 2026. Peter Hager, the company's current President and CEO, was appointed to fill these roles on an interim basis for a 30-day term effective November 3, 2026. The resignation was not due to any disagreement with the company's operations or policies.

8:09 AM ET 8-K
Loan & Debt Carnival Corp Ltd. CCL

Carnival Corp $2B Debt Financing

Carnival Corporation established a $2.0 billion unsecured commercial paper program guaranteed by Carnival UK Ltd. The short-term notes will have maturities of up to 180 days and proceeds will be used for general corporate purposes, with the company's revolving credit facility serving as a liquidity backstop.

Value
$2B
Term
up to 180 days
8:08 AM ET 8-K
Financial Results UroGen Pharma Ltd. URGN

UroGen Pharma Financial Results

UroGen Pharma reported third-quarter 2026 financial results, highlighted by $68.0 million in ZUSDURI revenue, representing 35% sequential growth. The company also announced that the FDA has accepted its NDA for UGN-103 with a PDUFA goal date of June 14, 2027, and reported a cash position of $215.4 million.

“We delivered another strong quarter of execution, with ZUSDURI continuing to scale as growing repeat utilization, expanding community adoption, and broader physician engagement reinforce our confidence in the long-term commercial opportunity.”

Liz Barrett, President and Chief Executive Officer of UroGen

“The U.S. Food and Drug Administration’s (FDA’s) acceptance of the UGN-103 New Drug Application (NDA) in low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC), together with our newly issued patent providing coverage into July 2044, further reinforce the long-term revenue potential of our bladder cancer portfolio.”

Liz Barrett, President and Chief Executive Officer of UroGen
8:08 AM ET 8-K
Financial Results Southwest Gas Holdings, Inc. SWX

Southwest Gas Holdings Financial Results

Southwest Gas Holdings reported Q3 2026 financial results, highlighted by a return to profitability in continuing operations with net income of $12.8 million compared to a loss in the prior year. The company reaffirmed its full-year 2026 guidance and noted the completion of rate cases in Nevada and California that will increase annual revenue by approximately $80 million.

“Our strong results give us confidence that we are on track to achieve our full-year guidance. We achieved several important regulatory milestones, completing our Nevada and California rate cases, which resulted in approximately $80 million of combined annual revenue increases, reinforcing regulatory support for infrastructure investments and enhancing earnings visibility.”

Justin Brown, President and CEO of Southwest Gas Holdings
8:08 AM ET 10-Q
Financial Results Nuvectis Pharma, Inc. NVCT

Nuvectis Pharma Q3 2026 Results: Net Loss of $30.1M, Loss Widens

Nuvectis Pharma reported a significant increase in cash and cash equivalents to $140.7 million as of September 30, 2026, following a substantial equity issuance. However, the company continues to incur losses, with research and development expenses rising to $36.2 million for the first nine months of 2026 compared to $13.1 million in the prior year period.

Key figure
Net loss $30.1M
8:05 AM ET 8-K
Financial Results SmartRent, Inc. SMRT

SmartRent Financial Results

SmartRent reported Q3 2026 financial results featuring 15% total revenue growth and its fourth consecutive quarter of positive Adjusted EBITDA. The company achieved significant margin expansion, with gross margins reaching 41%, and reported that total units deployed reached nearly 942,000 as it executes its Vision 2028 Strategic Plan.

Term
Q3 2026

“SmartRent has now delivered four successive quarters of accelerating growth and margin trends as we successfully execute against our Vision 2028 Strategic Plan. The positive momentum extends across all facets of the business including our sales muscle, critical technology advancements and operations effectiveness.”

Frank Martell, President and Chief Executive Officer of SmartRent

“Total Revenue increased 15% year-over-year, with Core Revenue up 24%. As our footprint continues to scale, we are seeing expanding adoption of our Access Control and Self-Guided Tour solutions, alongside strong demand for equipment upgrades and refreshes.”

Daryl Stemm, Chief Financial Officer of SmartRent
8:04 AM ET 8-K
Leadership Change Jones Lang Lasalle Inc JLL

Jones Lang Lasalle Leadership Change

Jones Lang LaSalle (JLL) has elected Nabeel Al-Amudi and Toni Townes-Whitley as independent, non-executive members of its Board of Directors, effective December 1, 2026. Al-Amudi brings experience in global investment and infrastructure, while Townes-Whitley provides expertise in technology and regulated industries. Both will serve on the Audit & Risk and Compensation Committees through the 2027 Annual Meeting of Shareholders.

8:04 AM ET 8-K
Financial Results Avnet Inc AVT

Avnet Financial Results

Avnet reported record first quarter fiscal 2027 sales of $10.7 billion, an 82% increase year-over-year, driven by strong demand in industrial, aerospace, and AI data center applications. The company achieved record adjusted diluted EPS of $3.63 and expanded its adjusted operating income margin by 210 basis points to 4.7%.

Term
Q1 2027

“We began fiscal 2027 by delivering another record quarter, reflecting stronger demand and solid execution across all of our businesses. The fundamental backdrop for our industry remains positive, with continued growth across our core verticals such as industrial, aerospace and defense, transportation and AI and data center applications.”

Phil Gallagher, Avnet Chief Executive Officer
8:04 AM ET 8-K
Financial Results W.W. Grainger, Inc. GWW

W.W. Grainger Financial Results

W.W. Grainger reported third quarter 2026 sales of $5.2 billion, an 11.3% increase year-over-year, driven by strong performance in both High-Touch Solutions and Endless Assortment segments. The company achieved adjusted diluted EPS of $12.54 and increased its full-year 2026 earnings outlook due to consistent execution and improving demand.

Term
Q3 2026

“The third quarter performance reflects our consistent execution and an improving demand environment. As customers continue to turn to us for the products and solutions they need, both our High-Touch Solutions and Endless Assortment segments delivered impressive growth. Following another quarter of strong performance, we are increasing our 2026 guidance and remain on track for an exceptional year.”

D.G. Macpherson, Chairman and CEO
8:03 AM ET 10-Q
Financial Results Trinity Capital Inc. TRIN

Trinity Capital Q3 2026 Results: Net Income $46.9M, Up 69.7% YoY

Trinity Capital Inc. reported a net increase in net assets resulting from operations of $121.2 million for the nine months ended September 30, 2026, compared to $96.1 million in the prior year period. Total investment income grew significantly to $275.7 million for the nine months, driven by an expanded investment portfolio which reached a fair value of $2.86 billion.

Key figure
Net income $46.9M · +69.7% YoY
8:03 AM ET 10-Q
Financial Results Atlanta Braves Holdings, Inc. BATRA

Atlanta Braves Holdings Q3 2026 Results: Net Income $9.8M, Down 67.3% YoY

For the nine months ended September 30, 2026, Atlanta Braves Holdings reported total revenue of $701.8 million, a 4.6% increase over the prior year, though it swung to an operating loss of $51.1 million compared to a profit in 2025. The net loss attributable to stockholders was $42.9 million, driven primarily by a significant increase in baseball operating costs and selling, general, and administrative expenses.

Key figure
Net income $9.8M · -67.3% YoY
8:01 AM ET 8-K
Financial Results Reservoir Media, Inc. RSVR

Reservoir Media Financial Results

Reservoir Media reported second quarter fiscal 2027 revenue of $49.9 million, a 10% increase year-over-year driven by strong performance in Recorded Music and Music Publishing. Net income rose to $4.6 million, or $0.07 per share, and the company raised its full-year outlook for revenue and Adjusted EBITDA.

Term
Q2 2027

“Our second quarter results marked the end of a strong first half of fiscal 2027, with growth across both our Publishing and Recorded Music segments reflecting the continued successful execution of our long-term strategy.”

Golnar Khosrowshahi, Founder and Chief Executive Officer

“We continue to thoughtfully expand and diversify our portfolio, while deepening our established reputation as a trusted steward for exceptional music talents and catalogs. We remain confident in our ability to build on this momentum for the remainder of fiscal year 2027.”

Golnar Khosrowshahi, Founder and Chief Executive Officer
8:01 AM ET 10-Q
Financial Results Burford Capital Ltd BUR

Burford Capital Q3 2026 Results: Turns Profitable, Net Income $23.4M

Burford Capital Ltd's Form 10-Q for the period ended September 30, 2026, details the company's performance in the legal finance market, emphasizing realized gains from portfolio resolutions and the valuation of capital provision assets. The report provides updates on liquidity management and the scaling of its investment portfolio amidst evolving litigation trends.

Key figure
Net income $23.4M
8:01 AM ET 8-K
Financial Results Trinity Capital Inc. TRIN

Trinity Capital Financial Results

Trinity Capital reported record third-quarter 2026 financial results, with net investment income (NII) growing 34.9% year-over-year to $49.9 million. The company funded $614.1 million in gross investments during the quarter, driving total platform assets under management to $3.4 billion. Net Asset Value (NAV) per share increased to $13.61, supported by a 15.5% return on average equity.

Term
Q3 2026

“The third quarter was another step in building a platform designed to perform across market environments. We funded $614 million, grew platform AUM to $3.4 billion, and continued to expand our managed funds offering, enhancing returns for TRIN beyond the income generated by our BDC portfolio. We like the foundation we’ve built, and we’re excited about what’s next for TRIN and our shareholders.”

Kyle Brown, Trinity Capital CEO
8:01 AM ET 10-Q
Financial Results Neuronetics, Inc. STIM ▶ Call

Neuronetics Q3 2026 Results: Net Loss of $1.69M, Loss Narrows

Neuronetics, Inc. reported total revenues of $41.96 million for the quarter ended September 30, 2026, a 12.5% increase over the prior year, driven primarily by growth in the Greenbrook segment. The company achieved a quarterly income from operations of $0.54 million compared to a loss of $7.32 million in the prior year, though it maintained a net loss of $1.56 million for the period.

Key figure
Net loss $1.69M
8:01 AM ET 8-K
Financial Results American Financial Group Inc AFG

American Financial Group Financial Results

American Financial Group reported record third quarter core net operating earnings of $3.97 per share, driven by higher net investment income and strong P&C operating performance. Alongside the results, the Board of Directors declared a special one-time cash dividend of $3.50 per share payable on November 25, 2026. The company also updated its full-year 2026 core net operating earnings guidance to a range of $12.30 to $12.80 per share.

Term
Q3 2026
8:01 AM ET 8-K
Financial Results Harmony Biosciences Holdings, Inc. HRMY

Harmony Biosciences Holdings Financial Results

Harmony Biosciences reported Q3 2026 financial results with WAKIX net revenue of $269 million, driven by 400 net patient additions. The company reaffirmed its full-year 2026 revenue guidance of $1.0 billion to $1.04 billion and announced that Peter Anastasiou will succeed Jeffrey Dayno as CEO effective January 1, 2027.

“As I prepare to transition the President and CEO role to Peter on January 1, I believe Harmony is operating from a position of strength, with a durable and growing WAKIX franchise, the financial flexibility to invest in innovation, conviction to pursue strategic business development opportunities, and a pipeline led by BP-205 that has the potential to generate significant long-term value.”

Jeffrey Dayno, MD, President and Chief Executive Officer

“I am proud of the talented team and passionate organization we have built, which position Harmony for continued success in delivering innovative treatments to patients and sustained value for our shareholders.”

Jeffrey Dayno, MD, President and Chief Executive Officer
8:01 AM ET 8-K
Leadership Change Childrens Place, Inc. PLCEQ

Childrens Place Leadership Change

The Children’s Place announced a major leadership shakeup including the resignations of Muhammad Asif Seemab as President and Interim CEO, Muhammad Umair as Chief Strategy Officer, and Turki Saleh A. AlRajhi as Executive Chairman. CFO John Szczepanski has assumed the role of acting President and principal executive officer, while AlRajhi will remain Chairman of the Board. Additionally, director Kim Roy resigned from the board effective October 30, 2026.

8:01 AM ET 8-K
Financial Results Burford Capital Ltd BUR

Burford Capital Financial Results

Burford Capital reported its financial results for the third quarter and first nine months of 2026, highlighting total revenues of $135 million. The company achieved $100 million in de-leveraging and ended the period with over $500 million in cash on hand.

Term
Q3 2026

“Burford had its strongest quarter this year, with robust portfolio activity and good cash generation. Total revenues of $135 million would have been well over $200 million if not for the non-cash increase in market discount rates. We also achieved $100 million of de-leveraging and retired our nearest-term debt maturity. We closed the quarter with more than a half-billion dollars of cash on hand.”

Christopher Bogart, Burford Capital’s Chief Executive Officer
8:01 AM ET 8-K
Financial Results Atlanta Braves Holdings, Inc. BATRA

Atlanta Braves Holdings Financial Results

Atlanta Braves Holdings reported third quarter 2026 financial results, with total revenue increasing 4% to $325 million driven by higher baseball event revenue and mixed-use development rental income. Operating income declined significantly to $9 million from $39 million in the prior year period, primarily due to increased player salaries. The company highlighted a 14% increase in average regular season home game attendance and the successful first season of its direct-to-consumer platform, BravesVision.

Term
3 months

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.